Post Marketing Information DHCPL 05/03/2018 Risk of gadolinium brain deposits associated with use of gadolinium-based contrast agents
INTRAVENOUS Select a brand starting with the letter: P PRIMOVIST 0.25 MMOL/ML SOLUTION FOR INJECTION [SIN13308P] PRIMOVIST SOLUTION FOR INJECTION IN VIAL 0.25 MMOL/ML [SIN16559P]